Company Overview of Origen Therapeutics, Inc.
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Emeryville, California.
5885 Hollis Street
Emeryville, CA 94608
Founded in 1997
Key Executives for Origen Therapeutics, Inc.
Similar Private Companies By Industry
|Femta Pharmaceuticals, Inc.||United States|
|Dance BioPharm Inc.||United States|
|MEDIPOST America, Inc.||United States|
|Cell-Matrix, Inc.||United States|
|Palmera Holdings, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Origen Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.